Do current COVID-19 vaccines and treatments neutralise Omicron? New research has looked into a number of medications currently approved for use in Australia, as well as the role of a booster shot against the highly-infectious variant.
What is the latest on COVID-19 treatments available in Australia? As infection rates continue to reach record highs, newsGP breaks down the latest treatments available for people who have the viral infection.
Mixed response to latest Solidarity trial COVID findings No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
Gold standard trial finds remdesivir shortens duration of COVID-19 The results have confirmed doctors’ experiences of treating COVID patients in Australia.
US purchasing global supply of COVID-19 drug raises ethical questions Gilead Sciences has donated a supply of remdesivir to Australia’s national medical stockpile. But what if cases continue to rise?
Antiviral becomes first recommended treatment for COVID-19 newsGP speaks with the Chair of Australia’s National COVID-19 Clinical Evidence Taskforce about the recommended use of remdesivir.
Remdesivir under review by national COVID-19 taskforce newsGP speaks to taskforce Chair Associate Professor Julian Elliott about the latest guidance for the care of coronavirus patients.
Remdesivir and COVID-19: What GPs need to know It has become the first therapy for COVID-19 to receive FDA approval for emergency use – but evidence of its effectiveness remains mixed.